Importantly, considerable reductions in PD‐L1 expression were seen in tumor slices from mice treated with ABNM@TMZ/OTX (Figure 4H), supporting the efficient modulation of PD‐L1 by nanomedicine‐delivered OTX. The gene discussed is CD274; the disease is neoplasm.